| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | Enterprise Standards |
| Suitable for: | Adult |
| State: | Powder |
| Purity: | >98% |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Wuhan HHD Supply Pharmaceutical API CAS 366789-02-8 Bulk Rivaroxaban Powder
| Product Name | Factory Supply API cas 366789-02-8 bulk Rivaroxaban powder |
| Appearance | White powder |
| Molecular formula | C19h18cln3o5s |
| Molecular Weight | 453.88 |
| Keywords | Rivaroxaban ,Rivaroxaban powder,bulk Rivaroxaban powder |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
What is Rivaroxaban ?
Rivaroxaban is an oral anticoagulant. It is an orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible
There is currently no specific way to reverse the anticoagulant effect of rivaroxaban in the event of a major bleeding event,
Function of Rivaroxaban
Rivaroxaban is an oral anticoagulant. It is an orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
There is currently no specific way to reverse the anticoagulant effect of rivaroxaban in the event of a major bleeding event, unlike ...
Application of Rivaroxaban
1.Rivaroxaban can be used to prevent strokes in those with atrial fibrillation due to causes other than heart valvedisease, and at least one additional risk factor for stroke (congestive heart failure, hypertension, age, diabetes, and prior stroke).
2.Rivaroxaban can also be used to prevent the formation of blood clots in the veins (deep venous thrombosis) in adults who have had an operation to replace a hip or knee and for treatment and prevention of acute deep venous thrombosis in adults. It can not be used for prevention of venous thrombosis in hospitalized medically ill patients.
3.Rivaroxaban is not indicated for prosthetic heart valves or for mitral stenosis
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}